Fubotv earnings beat by $0.10, revenue topped estimates
In a challenging economic climate, shares of cbdMD, Inc. (NYSE:YCBD) have reached a 52-week low, dipping to $0.31. The company, known for its broad range of CBD products, has faced significant headwinds over the past year, reflected in a substantial 1-year change with a decline of -55.52%. According to InvestingPro data, the company’s financial health score stands at 1.81 (Fair), with revenue declining 18% over the last twelve months to $19.22M. Investors have shown concern as the stock struggles to find its footing amidst a volatile market, regulatory uncertainties, and intense competition within the CBD industry. The current price level marks a critical juncture for YCBD as it navigates through these market pressures and aims to regain investor confidence. InvestingPro analysis suggests the stock is currently undervalued, with 12 additional exclusive insights available to subscribers, including detailed cash flow metrics and profitability forecasts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.